https://fdawatch.net/2026/03/30/fdas-regulatory-revisions-business-legal-impact-on-industry-part-2-medical-devices/https://fdawatch.net/wp-content/uploads/2026/03/carolyn-bruguera-768x768-1.jpgcarolyn-bruguera-768x768https://fdawatch.net/wp-content/uploads/2026/03/gasaway_michelle_5x7.jpg2018 BrioPhoto copyrighthttps://fdawatch.net/wp-content/uploads/2026/03/ridgway_william_5x7.jpgRidgway_William_5x72026-03-30T13:29:46+00:00monthlyhttps://fdawatch.net/2026/03/23/fdas-regulatory-revisions-business-legal-impact-on-industry-part-1-pharmaceuticals/https://fdawatch.net/wp-content/uploads/2026/03/tess-cameron.jpgTess-Cameronhttps://fdawatch.net/wp-content/uploads/2026/03/ickes_kendall_5x7.jpgIckes_Kendall_5x7https://fdawatch.net/wp-content/uploads/2026/03/fox_raquel_5x7.jpgGittingsLegal - NE75543GittingsLegal - NE75543https://fdawatch.net/wp-content/uploads/2026/03/turow_rachel_5x7.jpgturow_rachel_5x72026-03-23T14:14:45+00:00monthlyhttps://fdawatch.net/2026/03/16/medical-device-regulation-compliance-policy-part-4-digital-health-consumers/https://fdawatch.net/wp-content/uploads/2026/03/jackiehaydock.pngJackieHaydockhttps://fdawatch.net/wp-content/uploads/2026/03/dworkin_olivia_1000x714_env.jpgDworkin_Olivia_1000x714_ENVhttps://fdawatch.net/wp-content/uploads/2026/03/kuhn_christina_1000x714_env.jpgKuhn_Christina_1000x714_ENVhttps://fdawatch.net/wp-content/uploads/2026/03/davenport_kristin_1000x714_env.jpgDavenport_Kristin_1000x714_ENV2026-03-16T14:04:33+00:00monthlyhttps://fdawatch.net/2026/03/09/medical-device-regulation-compliance-policy-part-3-on-false-claims/https://fdawatch.net/wp-content/uploads/2026/03/rosen-moller_krysten_1000x714_env.jpgGittings Global - NE94677Gittings Global - NE94677https://fdawatch.net/wp-content/uploads/2026/03/forrest_pamela_1000x714_env.jpgGittings Global - NE94685Gittings Global - NE94685https://fdawatch.net/wp-content/uploads/2026/03/granston_michael_1000x714_env.jpgGranston_Michael_1000x714_ENV2026-03-09T13:14:31+00:00monthlyhttps://fdawatch.net/2026/03/02/fda-reporter-roundtable-a-view-from-the-news-desk/https://fdawatch.net/wp-content/uploads/2026/03/derrick-gingery-informa-photo.jpgDerrick Gingery-Informa photohttps://fdawatch.net/wp-content/uploads/2026/03/sarah-500x500-1.jpgSarah-500x500https://fdawatch.net/wp-content/uploads/2026/03/dsc05550.jpgDSC055502026-03-02T14:49:20+00:00monthlyhttps://fdawatch.net/2026/02/23/forever-chemicals-and-cosmetics-oversight-in-2026/https://fdawatch.net/wp-content/uploads/2026/02/almondhiry_rend_uc1920488-e1771867730257.jpgAlMondhiry_Rend_uc19204882026-02-23T17:39:37+00:00monthlyhttps://fdawatch.net/2026/02/17/medical-device-regulation-compliance-policy-part-2-a-look-at-europe-china/https://fdawatch.net/wp-content/uploads/2026/02/post_julia_1000x714_env.jpgGittings Photography - PostGittings Photography - Posthttps://fdawatch.net/wp-content/uploads/2026/02/balzano_john_1000x714_env.jpgGittings Photography - Balzanohttps://fdawatch.net/wp-content/uploads/2026/02/cowlishaw_sarah_1000x714_env.jpgGittings Global - NE123178Gittings Global - NE1231782026-02-17T17:11:57+00:00monthlyhttps://fdawatch.net/2026/02/09/fdas-2026-food-priorities/2026-02-09T14:43:31+00:00monthlyhttps://fdawatch.net/2026/02/02/medical-device-regulation-compliance-policy-part-1-ldts-in-focus/https://fdawatch.net/wp-content/uploads/2026/02/susanvanmeter.jpgSusanVanMeterhttps://fdawatch.net/wp-content/uploads/2026/02/danzis.jpgDanzishttps://fdawatch.net/wp-content/uploads/2026/02/amyleiser.jpgGittings Global - NE105538Gittings Global - NE1055382026-02-02T13:55:13+00:00monthlyhttps://fdawatch.net/2026/01/26/fdas-evolving-approach-to-medical-device-reviews/https://fdawatch.net/wp-content/uploads/2026/01/mike-ryan-headshot.jpegMike Ryan- headshot2026-01-26T14:59:47+00:00monthlyhttps://fdawatch.net/2026/01/12/inside-fda-pharma-policy-development/https://fdawatch.net/wp-content/uploads/2026/01/jamiegamerman.jpegJamieGamermanhttps://fdawatch.net/wp-content/uploads/2026/01/rumiyoung.jpgRumiYoung2026-01-12T15:49:34+00:00monthlyhttps://fdawatch.net/2025/12/22/year-end-review-and-a-look-ahead/2025-12-23T13:10:10+00:00monthlyhttps://fdawatch.net/2025/12/08/deregulation-ai-more-with-dr-ritu-nalubola/https://fdawatch.net/wp-content/uploads/2025/12/ritunalubola.jpgRituNalubola2025-12-08T14:58:25+00:00monthlyhttps://fdawatch.net/2025/12/01/pharmaceutical-regulation-compliance-policy-part-4-dispute-resolution-for-drugs-and-biological-products/https://fdawatch.net/wp-content/uploads/2025/12/josephinetorrente.pngJosephineTorrentehttps://fdawatch.net/wp-content/uploads/2025/12/charlesraver.pngCharlesRaverhttps://fdawatch.net/wp-content/uploads/2025/12/michellebutler.pngMichelleButler2025-12-01T15:37:20+00:00monthlyhttps://fdawatch.net/2025/11/10/pharmaceutical-regulation-compliance-policy-part-3-a-close-look-at-generic-drugs/https://fdawatch.net/wp-content/uploads/2025/11/karinhessler.jpgKarinHesslerhttps://fdawatch.net/wp-content/uploads/2025/11/kurtkarst.pngKurtKarsthttps://fdawatch.net/wp-content/uploads/2025/11/sarakoblitz.pngSaraKoblitz2025-12-01T15:26:41+00:00monthlyhttps://fdawatch.net/2025/11/24/key-issues-shaping-cosmetics-and-personal-care-oversight/https://fdawatch.net/wp-content/uploads/2025/11/ronieschmelz.pngRonieSchmelzhttps://fdawatch.net/wp-content/uploads/2025/11/rachelraphael.jpgRachelRaphael2025-11-24T14:02:38+00:00monthlyhttps://fdawatch.net/2025/11/17/how-industry-is-adapting-to-fdas-food-shifts/https://fdawatch.net/wp-content/uploads/2025/11/sarahgallo.jpgSarahGallohttps://fdawatch.net/wp-content/uploads/2025/11/sarahsorscher.jpgSarahSorscher2025-11-17T14:25:37+00:00monthlyhttps://fdawatch.net/2025/11/03/pharmaceutical-regulation-compliance-policy-part-2-navigating-the-new-enforcement-environment/https://fdawatch.net/wp-content/uploads/2025/11/peterdickos.pngPeterDickoshttps://fdawatch.net/wp-content/uploads/2025/11/andrewhull.pngAndrewHullhttps://fdawatch.net/wp-content/uploads/2025/11/johnclaud.pngJohnClaud2025-11-03T13:36:12+00:00monthlyhttps://fdawatch.net/2025/10/27/examining-cdrh-device-innovation-agency-communication/https://fdawatch.net/wp-content/uploads/2025/10/stevesilverman.jpgSteveSilvermanhttps://fdawatch.net/wp-content/uploads/2025/10/sandy-kalter-profile-photo-2018-1.jpgSandy Kalter Profile Photo 2018 (1)2025-10-27T13:16:58+00:00monthlyhttps://fdawatch.net/2025/10/20/a-look-at-fdas-drug-review-reset/https://fdawatch.net/wp-content/uploads/2025/10/elizabethjungman.jpgElizabethJungmanhttps://fdawatch.net/wp-content/uploads/2025/10/cartieresham-e1760975741505.jpgCartierEsham2025-10-20T16:57:36+00:00monthlyhttps://fdawatch.net/2025/10/16/pharmaceutical-regulation-compliance-policy-part-1-the-evolving-regulatory-landscape-of-rare-diseases/https://fdawatch.net/wp-content/uploads/2025/10/katemccurdy.jpgKateMcCurdyhttps://fdawatch.net/wp-content/uploads/2025/10/louisehimmelstrup.jpegLouiseHimmelstruphttps://fdawatch.net/wp-content/uploads/2025/10/franksasinowski.pngFrankSasinowskihttps://fdawatch.net/wp-content/uploads/2025/10/jamesvalentine.pngJamesValentine2025-10-16T12:58:27+00:00monthlyhttps://fdawatch.net/2025/09/15/unpacking-omufa/https://fdawatch.net/wp-content/uploads/2025/09/meredithpetillo.jpgMeredithPetillo2025-09-15T15:40:23+00:00monthlyhttps://fdawatch.net/2025/09/08/fdas-fight-against-ultraprocessed-foods/https://fdawatch.net/wp-content/uploads/2025/09/lewis_claudia-a_high.jpgLewis_Claudia-Acalewishttps://fdawatch.net/wp-content/uploads/2025/09/ricardocarvajal.pngRicardoCarvajal2025-09-08T13:32:06+00:00monthlyhttps://fdawatch.net/2025/09/02/dissecting-the-direction-of-cder-and-cber-with-paul-kim/https://fdawatch.net/wp-content/uploads/2025/09/1000019332.png10000193322025-09-02T13:10:56+00:00monthlyhttps://fdawatch.net/2025/08/26/medical-device-oversight-in-a-changing-landscape/https://fdawatch.net/wp-content/uploads/2025/08/bobbi-profile-favorite-1.jpgBobbi Profile Favorite 12025-08-26T13:38:37+00:00monthlyhttps://fdawatch.net/2025/08/11/vaccines-pharmaceutical-policy-fdas-next-moves/https://fdawatch.net/wp-content/uploads/2025/08/pauloffit.jpgPaulOffithttps://fdawatch.net/wp-content/uploads/2025/08/debautor.pngDebAutor2025-08-11T15:45:22+00:00monthlyhttps://fdawatch.net/2025/08/07/fdas-past-present-future/https://fdawatch.net/wp-content/uploads/2025/08/johntaylor.pngJohnTaylor2025-08-07T12:36:09+00:00monthlyhttps://fdawatch.net/2025/01/13/whats-coming-in-device-cybersecurity-and-digital-health-product-regulation/https://fdawatch.net/wp-content/uploads/2025/01/johnsawyer.jpgJohnSawyerhttps://fdawatch.net/wp-content/uploads/2025/01/neiloflaherty.jpegNeilOFlaherty2025-08-06T20:26:56+00:00monthlyhttps://fdawatch.net/2025/01/20/the-new-look-fda-whats-on-the-horizon/https://fdawatch.net/wp-content/uploads/2025/01/grossman.jpggrossmanhttps://fdawatch.net/wp-content/uploads/2025/01/scheinesonmarc-e1737379640611.jpgscheinesonmarc2025-08-06T20:26:43+00:00monthlyhttps://fdawatch.net/2025/02/03/food-regulation-and-safety-under-the-new-administration/https://fdawatch.net/wp-content/uploads/2025/01/pape_stuart_smpap_crophires.jpgPape_Stuart_SMPAP_CropHiReshttps://fdawatch.net/wp-content/uploads/2025/01/veneziano.jpgVeneziano2025-08-06T20:26:32+00:00monthlyhttps://fdawatch.net/2025/03/03/the-evolution-of-clinical-trials/https://fdawatch.net/wp-content/uploads/2025/03/brogno.jpegBrogno2025-08-06T20:26:19+00:00monthlyhttps://fdawatch.net/2025/03/17/whats-happening-in-software-and-device-regulation/https://fdawatch.net/wp-content/uploads/2025/03/gaba-e1742215082723.jpgGabahttps://fdawatch.net/wp-content/uploads/2025/03/screenshot-2025-03-11-at-10.10.40e280afam.pngScreenshot 2025-03-11 at 10.10.40 AM2025-08-06T20:26:04+00:00monthlyhttps://fdawatch.net/2025/03/31/the-latest-in-fdas-focus-on-foods/https://fdawatch.net/wp-content/uploads/2025/03/peterlurie.jpgCSPI Staffhttps://fdawatch.net/wp-content/uploads/2025/03/susanmayne.jpgSusanMayne2025-08-06T20:25:53+00:00monthlyhttps://fdawatch.net/2025/04/01/a-new-era-of-unprecedented-change/https://fdawatch.net/wp-content/uploads/2025/04/myers-600x400-400x267-1-e1743509172245.jpgmyers-600x400-400x2672025-08-06T20:25:43+00:00monthlyhttps://fdawatch.net/2025/04/07/examining-the-cosmetics-compliance-and-enforcement-landscape/https://fdawatch.net/wp-content/uploads/2025/04/justinprochnow.jpgJustinProchnow2025-08-06T20:25:32+00:00monthlyhttps://fdawatch.net/2025/04/15/ai-medical-products-fda-part-1-ai-overview-in-life-sciences/https://fdawatch.net/wp-content/uploads/2025/04/luarensilvis.jpgLuarenSilvishttps://fdawatch.net/wp-content/uploads/2025/04/ethandabbs.jpgEthanDabbshttps://fdawatch.net/wp-content/uploads/2025/04/habtemariam_abeba.jpghabtemariam_abebahttps://fdawatch.net/wp-content/uploads/2025/04/kracov_daniel.jpgkracov_daniel2025-08-06T20:25:13+00:00monthlyhttps://fdawatch.net/2025/04/17/the-state-of-protection-innovation-communication-at-fda/https://fdawatch.net/wp-content/uploads/2025/04/ralphhall.webpRalphHallhttps://fdawatch.net/wp-content/uploads/2025/04/ronbartek.jpgRonBartek2025-08-06T20:25:01+00:00monthlyhttps://fdawatch.net/2025/04/21/breaking-down-pharma-in-the-current-environment/https://fdawatch.net/wp-content/uploads/2025/04/minsk_alan_5x7.jpgMinsk_Alan_5x7https://fdawatch.net/wp-content/uploads/2025/04/screenshot-2025-04-21-at-10.45.23e280afam.pngScreenshot 2025-04-21 at 10.45.23 AM2025-08-06T20:24:51+00:00monthlyhttps://fdawatch.net/2025/04/28/devices-disruption-the-road-ahead/https://fdawatch.net/wp-content/uploads/2025/04/kahan_jonatha_h00107_1.jpgKahan_Jonatha_H00107_1https://fdawatch.net/wp-content/uploads/2025/04/schultz.jpgschultz2025-08-06T20:24:15+00:00monthlyhttps://fdawatch.net/2025/01/06/key-pharmaceutical-regulation-issues-for-the-new-administration/2025-08-05T11:21:01+00:00monthlyhttps://fdawatch.net/2025/02/10/a-deep-dive-into-mocra/https://fdawatch.net/wp-content/uploads/2025/02/david-lennarz.jpegDavid Lennarzhttps://fdawatch.net/wp-content/uploads/2025/02/willwoodlee.jpgWillWoodlee2025-08-05T11:20:39+00:00monthlyhttps://fdawatch.net/2025/02/17/navigating-fdas-future-janet-woodcock-on-the-evolving-regulatory-landscape/https://fdawatch.net/wp-content/uploads/2025/02/janetwoodcock181_large_final_flag_900x900.jpgJanetWoodcock181_large_final_FLAG_900x9002025-08-05T11:20:33+00:00monthlyhttps://fdawatch.net/2025/05/01/ai-medical-products-fda-part-2-ai-discovery-design-development/https://fdawatch.net/wp-content/uploads/2025/05/markotopalovic.jpgMarkoTopalovichttps://fdawatch.net/wp-content/uploads/2025/05/temkin_eva_330x378.jpgtemkin_eva_330x378https://fdawatch.net/wp-content/uploads/2025/05/sklamberg_howard_website.jpgsklamberg_howard_website2025-08-05T11:19:37+00:00monthlyhttps://fdawatch.net/2025/05/19/homing-in-on-food-supply-tariffs-infant-formula/https://fdawatch.net/wp-content/uploads/2025/05/tonypavel.pngTonyPavelhttps://fdawatch.net/wp-content/uploads/2025/05/hahn_martin_1050195v2.jpgHahn_Martin_1050195V22025-08-05T11:19:31+00:00monthlyhttps://fdawatch.net/2025/05/27/ai-medical-products-fda-part-3-ai-in-drug-device-commercialization/https://fdawatch.net/wp-content/uploads/2025/05/william-maisel-900x900-1.jpgwilliam-maisel-900x900https://fdawatch.net/wp-content/uploads/2025/05/davar_mahnu_website_330x378_b.jpgdavar_mahnu_website_330x378_bhttps://fdawatch.net/wp-content/uploads/2025/05/desjardins_phil_330x378.jpgdesjardins_phil_330x3782025-08-05T11:19:24+00:00monthlyhttps://fdawatch.net/2025/06/02/breaking-down-cosmetics-safety-imports-mocra/https://fdawatch.net/wp-content/uploads/2025/06/emily-manoso-headshot-full-resolution.jpgEmily-Manoso-Headshot-Full-Resolution2025-08-05T11:19:16+00:00monthlyhttps://fdawatch.net/2025/07/21/the-top-3-developments-of-2025-in-pharma-devices-cosmetics-food/https://fdawatch.net/wp-content/uploads/2025/07/frank_yiannas_flag.jpgFDA - Frank Yiannashttps://fdawatch.net/wp-content/uploads/2025/07/diesch_angela_uncropped1920x488.jpgDiesch_Angela_Uncropped1920x488https://fdawatch.net/wp-content/uploads/2025/07/davies_c_cbdav_hi-res.jpgdavies_c_cbdav_hi-reshttps://fdawatch.net/wp-content/uploads/2025/07/naomilowy.pngNaomiLowy2025-08-05T11:18:23+00:00monthlyhttps://fdawatch.net/about/https://fdawatch.net/wp-content/uploads/2024/12/garg-law-logo-web.jpggarg-law-logo-webhttps://fdawatch.net/wp-content/uploads/2024/12/waynepines.jpgWaynePineshttps://fdawatch.net/wp-content/uploads/2024/12/shellygarg1.jpgShellyGarg12025-08-01T18:12:27+00:00weekly0.6https://fdawatch.net/2024/12/10/trailer/2025-02-03T13:19:43+00:00monthlyhttps://fdawatch.netdaily1.02026-03-30T13:29:46+00:00